HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: D700010-JLR200v1 48/12/2769    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bandhuvula, P. Articles by Saba, J. D. Search for Related Content PubMed PubMed Citation Articles by Bandhuvula, P. Articles by Saba, J. D. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 48, 2769-2778, December 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

Methods

A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity

Padmavathi Bandhuvula¹, Henrik Fyrst¹ and Julie D. Saba²

Children's Hospital, Oakland Research Institute, Oakland, CA 94609

Published, JLR Papers in Press, September 13, 2007.

¹ P. Bandhuvula and H. Fyrst contributed equally to this work.

² To whom correspondence should be addressed. e-mail: jsaba{at}chori.org

Sphingosine-1-phosphate (S1P) lyase (SPL) catalyzes the conversion of S1P to ethanolamine phosphate and hexadecenal. This enzyme plays diverse roles in physiology and disease and, thus, may be useful as a disease marker and/or drug target. Unfortunately, the radioisotope-based assay currently used to quantify SPL activity is suboptimal. We have devised an assay using a commercially available (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro (NBD)-labeled fluorescent substrate. Alternatively, we provide a method for synthesis of the substrate from NBD-sphingosine. Enzyme activity is determined by following the formation of NBD-aldehyde product, which is isolated from unreacted substrate by lipid extraction and quantified after separation by HPLC using a C18 column. A fluorescent NBD-C18-sphingosine internal standard is used to control for extraction efficiency. The reaction is linear over 20 min and total protein concentrations of 20–200 mg/l. The sensitivity of the fluorescence assay is comparable to or better than that of the radioactive assay, and SPL levels as low as 8 pmol/mg/min were readily detected. Semicarbazide, a nonspecific SPL inhibitor, reduced SPL activity in vitro by 70% using both standard and fluorescence methods. Product inhibition was not observed using ethanolamine phosphate and a commercially available source of hexadecenal. This method is suitable for quantifying SPL activity in a variety of cell and tissue sources.

Supplementary key words high-performance liquid chromatography • (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro-sphingosine • sphingosine-1-phosphate • dihydrosphingosine-1-phosphate

Abbreviations: CLAP, chymostatin, leupeptin, antipain, and pepstatin A; DHS1P, dihydrosphingosine-1-phosphate; 2,4-DNPH, 2,4-dinitrophenylhydrazine; GFP, green fluorescent protein; LCBP, long-chain base phosphate; NBD, (7-nitro-2-1,3-benzoxadiazol-4-yl)-D-erythro; S1P, sphingosine-1-phosphate; Sphk1, sphingosine kinase 1; SPL, sphingosine-1-phosphate lyase; TBAP, tetrabutylammonium-dihydrogen phosphate

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?